Zhu, A.X., Meyerhardt, J.A., Blaszkowsky, L.S., Kambadakone, A.R., Muzikansky, A., Zheng, H., Clark, J.W., Abrams, T.A., Chan, J.A., Enzinger, P.C., Bhargava, P., Kwak, E.L., Allen, J.N., Jain, S.R., Stuart, K., Horgan, K., Sheehan, S., Fuchs, C.S., Ryan, D.P. and Sahani, D.V. (2010) Efficacy and safety of gemcitabine, oxaliplatin, and bevacizumab in advanced biliary-tract cancers and correlation of changes in 18-fluorodeoxyglucose PET with clinical outcome: A phase 2 study. Lancet Oncology, 11, 48-54.